ライフサイエンスコーパス: ophthalmic

1 and The Armed Forces Institute of Pathology Ophthalmic Alumni Society) from 1975 through 2014 were r

2 All participants underwent a complete ophthalmic and electrophysiologic exploration and were r

3 We report ophthalmic and genetic findings in patients with autosom

4 At first visit, all patients had a detailed ophthalmic and medical history, comprehensive ophthalmic

5 resources more available for truly emergent ophthalmic and medical issues.

6 Results of ophthalmic and neuroradiologic assessment and sequence a

7 Ophthalmic and systemic evaluations and serologic testin

8 dian of 22 months by use of serial systemic, ophthalmic, and imaging examinations.

9 curate evaluations of the eye circulation in ophthalmic applications.

10 For the assessments of ophthalmic arteries, mean sensitivity was 0.69 (range 0.

11 ogram showed an anastomosis between the left ophthalmic artery and anterior deep temporal artery as a

12 g class 3 retinoblastoma vitreous seeds with ophthalmic artery chemosurgery (OAC) alone versus OAC wi

13 Assess the usefulness of second-course ophthalmic artery chemosurgery (OAC) for patients with i

14 Ophthalmic artery chemosurgery (OAC) has emerged as a pr

15 of these eyes were treated with concomitant ophthalmic artery chemosurgery (OAC).

16 Ophthalmic artery chemosurgery and intravitreous chemoth

17 Ophthalmic artery chemosurgery for advanced intraocular

18 rm outcomes of a devastating complication of ophthalmic artery emboli following Calcium Hydroxylapati

19 compare ocular perfusion pressure (OPP) and ophthalmic artery flow (OAF) between patients with NTG a

20 We report a case of iatrogenic ophthalmic artery occlusion after Embozene(R) embolizati

21 al to the internal carotid system leading to ophthalmic artery occlusion and blindness.

22 A diagnosis of left ophthalmic artery occlusion was made.

23 All patients also had a comprehensive ophthalmic assessment including a detailed history, Ocul

24 rimary manifestation underwent comprehensive ophthalmic assessment, including retinal imaging and ele

25 The patients were taken through thorough ophthalmic assessments to determine any ocular complicat

26 sing a desktop retinal camera operated by an ophthalmic assistant.

27 hypertensive medication (ACE inhibitors, non-ophthalmic beta blockers, calcium channel blockers, diur

28 tinopathies were offered participation in an ophthalmic biobank (421 participants with vitreoretinopa

29 inopathies were prospectively enrolled in an ophthalmic biobank, approved by the Human Investigation

30 clusters formed exclusively in the infected ophthalmic branch of the TG.

31 ole in mitigating coverage gaps in emergency ophthalmic care and could be further investigated throug

32 rrection, and diagnoses for which continuous ophthalmic care was necessary.

33 uld help mitigate coverage gaps in emergency ophthalmic care.

34 c urban children often do not have access to ophthalmic care.

35 All were treated with standard ophthalmic care.

36 significantly reduce the burden of inpatient ophthalmic care.

37 Africa and accounts for about 3 % of serious ophthalmic cases in tropical countries.

38 1, 2012, to October 31, 2015, at a tertiary ophthalmic center.

39 tive case series included 43 patients from 2 ophthalmic centers in Colombia and Venezuela who underwe

40 6,576 intravitreal injections from 25 French ophthalmic centers were included.

41 abetic retinopathy were recruited from 22 UK ophthalmic centres.

42 thase (CBS) genes and their association with ophthalmic changes after flight in 49 astronauts.

43 Ophthalmic changes have occurred in a subset of astronau

44 bolism genes contribute to susceptibility to ophthalmic changes in astronauts.

45 al Space Station, some astronauts experience ophthalmic changes, including choroidal folds, optic dis

46 To establish the natural history of ophthalmic characteristics in Progeria patients and to d

47 The ophthalmic characteristics of patients who underwent ker

48 Baseline ophthalmic characteristics, including visual acuity and

49 ents with long-standing disease need regular ophthalmic checkups because they are at risk of developi

50 iding complementary information to patients' ophthalmic clinical evaluation and has usefulness as an

51 dopsin OCT can bring significant impact into ophthalmic clinics by providing a tool for the diagnosis

52 Associations between RNFL thickness and ophthalmic, cognitive and other predictors were assessed

53 .26; P = 0.002), diabetes mellitus (DM) with ophthalmic complications (OR, 1.89; CI, 1.10-3.24; P = 0

54 ildren with Progeria are at risk for serious ophthalmic complications owing to ocular surface disease

55 , stroke, hypercoagulable state, and DM with ophthalmic complications; associated with lower risk wer

56 154 children aged 5 to 15 years without any ophthalmic condition that would affect the VF (controls)

57 Outcomes reporting for ophthalmic conditions currently widely varies across hos

58 sed international standard outcomes sets for ophthalmic conditions to metrics currently reported by e

59 ormed the clinical management of a myriad of ophthalmic conditions.

60 t could significantly change the approach to ophthalmic counseling and therapeutic management in pati

61 Ophthalmic data were collected at baseline and yearly vi

62 ariables included a spectrum of demographic, ophthalmic, dermatologic, systemic, socioeconomic, or oc

63 Most ophthalmic devices approved via the FDA's PMA pathway ha

64 , nature, and regulatory mechanisms by which ophthalmic devices are iteratively modified after initia

65 Ophthalmic devices initially approved via the FDA's PMA

66 1979 and 2015, the FDA approved 168 original ophthalmic devices via the PMA pathway and 2813 subseque

67 equent postmarket modifications to Class III ophthalmic devices.

68 analyze inpatient admissions with a primary ophthalmic diagnosis from 2001 to 2014.

69 the optimal management of patients with both ophthalmic disease and cardiovascular comorbidities requ

70 Emergent ophthalmic disease can lead to permanent visual impairme

71 Conjunctivitis was the dominant ophthalmic disease followed by blepharitis.

72 automated testing of acuity in children with ophthalmic disease in an objective and accurate manner.

73 Awareness and knowledge of emergent ophthalmic disease may be important for early medical pr

74 NHANES could be a novel method for assessing ophthalmic disease prevalence in the United States.

75 ad relatively good acuity; however, advanced ophthalmic disease was associated with reduced acuity.

76 Awareness of each ophthalmic disease was determined by the proportion of r

77 od and Drug Administration approval to treat ophthalmic disease, and AMD was the most common conditio

78 lial growth factor (VEGF) medication use for ophthalmic disease, including bevacizumab, ranibizumab,

79 00 enrolled patients per general category of ophthalmic disease, overall and for each available medic

80 whose manipulation could be used to mitigate ophthalmic disease.

81 ual variation and the full spectrum of neuro-ophthalmic diseases affecting VA, stereoacuity remains a

82 evels of awareness and knowledge of emergent ophthalmic diseases are low.

83 ir versatile application in the treatment of ophthalmic diseases, including age-related macular degen

84 Ophthalmic diseases, such as age-related macular degener

85 positively impact visual acuity outcomes in ophthalmic diseases.

86 ge, 44.5 [27.3] years) in the US owing to an ophthalmic disorder-an annual rate of 16 per 100 000 pop

87 population of individuals with a variety of ophthalmic disorders.

88 spective analysis included 396 patients with ophthalmic DLBCL from January 1, 1973, through December

89 y 17.7%, and overall survival was greater in ophthalmic DLBCL than in DLBCL located outside the centr

90 presented a series of notable advantages for ophthalmic drug application.

91 mal models of human disease; improvements in ophthalmic drug delivery and attempts at patient stratif

92 issues are the key obstacles that hinder the ophthalmic drug delivery of many therapeutic compounds,

93 cles (SiNPs) are promising drug carriers for ophthalmic drug delivery.

94 k to the future, we argue that investment in ophthalmic drug development must continue to cover the w

95 We consider what ophthalmic drug discovery can learn from the sector in g

96 mostly to a single medication, cyclosporine ophthalmic emulsion (Restasis, Allergan, Irvine, CA), wh

97 eal opacification who underwent a diagnostic ophthalmic endoscopy procedure from March 2014 to May 20

98 hort of EVD survivors who underwent baseline ophthalmic evaluation at ELWA Hospital were retrospectiv

99 Children with Progeria should have an ophthalmic evaluation at the time of diagnosis and at le

100 iscussing the rationale and components of an ophthalmic evaluation for adult patients with and withou

101 tary Eye Clinic were submitted to a complete ophthalmic evaluation including SAP and Spectral Domain

102 All subjects had a complete ophthalmic evaluation including symptom assessment using

103 The same ophthalmic evaluation was performed at each follow-up vi

104 phthalmic and medical history, comprehensive ophthalmic evaluation, and carotid artery evaluation (by

105 All patients underwent a complete ophthalmic evaluation, including optical coherence tomog

106 The intake process mainly embraced ophthalmic evaluation, obtaining a medical history, and

107 Demographic data collection, ophthalmic evaluation, ultrasound scan, and systemic stu

108 ients with optic pit maculopathy, a complete ophthalmic evaluation, with fundus color photography and

109 was based on ophthalmic history and complete ophthalmic evaluation.

110 Cumulative risks of ophthalmic events were determined (Kaplan-Meier techniqu

111 ntified factors associated with receiving an ophthalmic examination after initial diabetes diagnosis.

112 Subjects underwent complete ophthalmic examination and AS-OCT imaging before and 6 w

113 All participants underwent an extensive ophthalmic examination and completed a questionnaire.

114 elve patients from 7 families underwent full ophthalmic examination and retinal imaging.

115 Every participant underwent a complete ophthalmic examination and was evaluated by a metabolic

116 was measured using a logMAR chart during an ophthalmic examination at baseline and follow-up.

117 Patients underwent a full ophthalmic examination at each visit.

118 All patients underwent a complete ophthalmic examination before the measurements.

119 Reference standard was full ophthalmic examination by an experienced clinician who w

120 inical trial participants underwent complete ophthalmic examination by retina specialists at a privat

121 ent unit (ETU) stay, visual acuity (VA), and ophthalmic examination findings.

122 refractive error across the life course, but ophthalmic examination in such cases to determine the re

123 All patients had undergone a comprehensive ophthalmic examination including FA, SD OCT, and OCT ang

124 Ophthalmic examination is recommended in patients with c

125 Prospective ophthalmic examination of children with EB presenting ov

126 Ophthalmic examination showed decreased visual acuity ra

127 Detailed ophthalmic examination was performed in seven sporadic a

128 On both occasions, a comprehensive ophthalmic examination was performed that included logMA

129 Basic ophthalmic examination was performed using a 3x magnifyi

130 Extensive ophthalmic examination was performed, including Early Tr

131 The remaining ophthalmic examination was unremarkable.

132 Participants underwent a detailed ophthalmic examination, accompanied by electrodiagnostic

133 All participants underwent complete ophthalmic examination, color fundus photography (used f

134 Results of a complete ophthalmic examination, full-field flash electroretinogr

135 Participants underwent an extensive ophthalmic examination, including best-corrected visual

136 All participants underwent a detailed ophthalmic examination, including Cirrus and Spectralis

137 participants (n = 540) underwent a detailed ophthalmic examination, including EDI SD OCT for measure

138 All subjects underwent routine neuro-ophthalmic examination, including Titmus stereoacuity me

139 itudinal clinical evaluation, including full ophthalmic examination, multimodal retinal imaging, peri

140 lysis of patients with an initially abnormal ophthalmic examination, significant healing of keratopat

141 refractive error, axial length, and complete ophthalmic examination.

142 ventions or Observation Procedures: Complete ophthalmic examination.

143 mily were recruited and underwent a detailed ophthalmic examination.

144 To assess the rate of obtaining ophthalmic examinations and factors associated with rece

145 ived complete preoperative and postoperative ophthalmic examinations for first eye and second eye cat

146 l infants and mothers underwent systemic and ophthalmic examinations from December 1 through December

147 We performed ophthalmic examinations on 290 of 454 individuals with s

148 e MFSD8 variants was reviewed and additional ophthalmic examinations were performed, including electr

149 ying IDH3A variants and performed additional ophthalmic examinations, including full-field electroret

150 ere assessed from comprehensive systemic and ophthalmic examinations, interviews, and laboratory inve

151 d family members who underwent comprehensive ophthalmic examinations.

152 ring their encounter or obtained from recent ophthalmic examinations.

153 aphy, pattern electroretinography, and neuro-ophthalmic examinations.

154 Demographic information, all abnormal ophthalmic findings (and median time to first diagnosis)

155 Prevalence of ophthalmic findings (intraocular inflammatory reactions

156 The mothers of all the children had no ophthalmic findings and did not report ocular symptoms d

157 Ophthalmic findings in MF can be highly variable.

158 The ophthalmic findings included vitreous amyloid (26/26, 10

159 We report the ophthalmic findings of a patient with type Ia glycogen s

160 in our analysis socio-demographic variables, ophthalmic findings, investigations and treatment.

161 as diagnosed based on genetic and multimodal ophthalmic findings.

162 were performed at enrollment and at routine ophthalmic follow-up visits scheduled at least 12 weeks

163 otype data were collected over the course of ophthalmic follow-up, spanning a period of 20 years, beg

164 For children who needed ophthalmic follow-up, the rate of return to clinic and b

165 Diagnosis of Stargardt disease was based on ophthalmic history and complete ophthalmic evaluation.

166 Ophthalmic history included a penetrating injury of the

167 Prospective Intraoperative and Perioperative Ophthalmic Imaging with Optical Coherence Tomography (PI

168 pproach that enables high-resolution in vivo ophthalmic imaging without the need for HAO.

169 There were around 48 000 ophthalmic inpatient admissions in the US costing $421 m

170 This study was conducted at the Rotterdam Ophthalmic Institute, Rotterdam, Netherlands.

171 with the Ocular Response Analyzer (Reichert Ophthalmic Instruments, Buffalo, NY).

172 Astronauts with ophthalmic issues had significantly higher plasma concen

173 tudy participants included all patients with ophthalmic issues in British Columbia, such as those of

174 -carbon metabolic pathway than those without ophthalmic issues.

175 itamin status were significant predictors of ophthalmic issues.

176 lf-study significantly improved retention of ophthalmic knowledge and diagnostic skills by the end of

177 women publishing original investigations in ophthalmic literature, but no increase in editorial auth

178 = 4.2; CI, 1.8-9.6; P = .001), diabetes with ophthalmic manifestations (OR = 7.0; CI, 1.7-28.3; P = .

179 tes the urgent need to evaluate and document ophthalmic manifestations in patients for timely managem

180 Additional ophthalmic manifestations included reduced brow hair, ma

181 The pace and chronicity of ophthalmic manifestations lacked strict correlation to m

182 Ophthalmic manifestations noted were hyperopia and signs

183 Ophthalmic manifestations of congenital Zika syndrome.

184 Ophthalmic manifestations of the Carney Complex have bee

185 The visual sequelae of these ophthalmic manifestations remain unknown.

186 French families affected by microcephaly and ophthalmic manifestations, and one other individual was

187 /AIDS, internal organ abscess, diabetes with ophthalmic manifestations, skin cellulitis/abscess, pyog

188 All patients had bilateral ophthalmic manifestations.

189 nvestment) of $30 807 referent to the direct ophthalmic medical costs expended.

190 hics, Medicare payments to ophthalmologists, ophthalmic medical services provided, and the most commo

191 imbursed services accounted for 85% of total ophthalmic Medicare payments in 2013, an 11% increase fr

192 rs' Medicare Part D prescribing patterns for ophthalmic medications and to estimate the potential sav

193 If Medicare negotiated the prices for ophthalmic medications at USVA rates, $1.09 billion woul

194 The use of ophthalmic medications increased 20% (P < .01).

195 etachment (RRD) in 7.5% of eyes; classic and ophthalmic migraine in 6.5% of eyes; hypoglycemia in 2.8

196 Special emphasis is given to ophthalmic modifiers in mice, especially those relevant

197 ained personnel to identify individuals with ophthalmic needs, focusing on African Americans >/=50 ye

198 department assistants and practitioners, and ophthalmic nursing staff.

199 After complete ophthalmic ocular examination including pupillary light

200 ACV 3% ophthalmic ointment is a valuable intervention for dendr

201 is is to demonstrate that acyclovir (ACV) 3% ophthalmic ointment is superior to idoxuridine (IDU) in

202 up of members of the American Association of Ophthalmic Oncologists and Pathologists (AAOOP) with sup

203 The panel included representative ophthalmic oncologists, pathologists, and geneticists fr

204 Expert panel of ophthalmic oncologists, pathologists, and geneticists.

205 Ten subspecialty ophthalmic oncology centers from 4 continents shared dat

206 h retrospective record review at an academic ophthalmic oncology practice.

207 gy, the fourteenth author's name in the AJCC Ophthalmic Oncology Task Force Member Authors section in

208 o study a heterogenous patient population in ophthalmic oncology.

209 In addition, median overall survival in ophthalmic-only disease was higher (84.0 months; 95% CI,

210 Patient demographics and systemic, ophthalmic, operative, and postoperative data from all c

211 Main outcome measure is consistency of ophthalmic outcomes measures reported.

212 s were significant predictors of many of the ophthalmic outcomes that we observed.

213 the variability seen in patients with neuro-ophthalmic pathologies included in the differential diag

214 Ophthalmic pathology in patients includes corneal haze a

215 merman Ophthalmic Pathology Society, Eastern Ophthalmic Pathology Society, and The Armed Forces Insti

216 eye pathologic societies (Verhoeff-Zimmerman Ophthalmic Pathology Society, Eastern Ophthalmic Patholo

217 ) to review the literature on readability of ophthalmic patient education materials and (2) to evalua

218 ematic review of the literature reveals that ophthalmic patient education materials are consistently

219 ies that have evaluated readability level of ophthalmic patient education materials, and the reported

220 embers, with the potential to reduce serious ophthalmic patient safety events.

221 between an ophthalmologist and two-mid level ophthalmic personnel (MLOPs).

222 yze the correlations between XP genotype and ophthalmic phenotype.

223 the following search terms: topical, ocular, ophthalmic, phenylephrine, tropicamide, cardiovascular e

224 These results from members of ophthalmic plastic and reconstructive surgery societies

225 All surgeons were members of ophthalmic plastic and reconstructive surgery societies.

226 onomic effect of implementing an EHR into an ophthalmic practice is warranted.

227 serve the public by improving the quality of ophthalmic practice through a continuing certification p

228 Bandage contact lenses are commonly used by ophthalmic practitioners to protect the patient's cornea

229 ents with MF demonstrating a highly variable ophthalmic presentation of this disease.

230 A total of 31.1% of all patients had an ophthalmic procedure, pars plana vitrectomy (4.8%) being

231 Ophthalmic products containing polyquaternium-1 may caus

232 tial value of targeting children in national ophthalmic public policies tackling inequalities.

233 The initial presenting ophthalmic records of patients with either SJS (<30% bod

234 urred outside the central nervous system and ophthalmic regions (46.0 months; 95% CI, 44.4-47.6 month

235 cated outside the central nervous system and ophthalmic regions.

236 s the experience of progressing from a young ophthalmic resident to a full-time professional and, ult

237 ic variability and highlighting the need for ophthalmic review of these patients.

238 Current guidelines suggest that ophthalmic screening begin 3 to 5 years after initial di

239 can Academy of Ophthalmology recommends that ophthalmic screening for DR occur beginning at 5 years a

240 nsus statement from the panel: (1) Dedicated ophthalmic screening is recommended for all children at

241 Presented is the ophthalmic screening protocol developed in response to t

242 We propose an ophthalmic screening protocol to diagnose retinitis in p

243 m was formed to review the literature and an ophthalmic screening protocol was developed.

244 Ophthalmic screening to check for diabetic retinopathy (

245 l appointments with the new Scottish general ophthalmic service and Eyecare Integration Programme.

246 and after implementation of the new general ophthalmic service contract in 2006, the Eyecare Integra

247 , while average dollar amount reimbursed per ophthalmic service decreased by 5.4%.

248 analyze trends in utilization and payment of ophthalmic services in the Medicare population for years

249 proportion of individuals screened required ophthalmic services, particularly those who were older a

250 nicipalities with fewer inhabitants and less ophthalmic services.

251 ded, and the most common Medicare-reimbursed ophthalmic services.

252 Comprehensive ophthalmic slitlamp examination was conducted.

253 0.09 % and chondroitin sulfate 0.1 % (XG/CS) ophthalmic solution (n = 76) or a fixed combination of p

254 were randomized (1:1:1) to receive AL-8309B ophthalmic solution 1.0%, 1.75%, or vehicle, administere

255 1 after 14-day placebo run-in to lifitegrast ophthalmic solution 5.0% or placebo twice daily for 84 d

256 ticipants were randomized 1:1 to lifitegrast ophthalmic solution 5.0% or placebo twice daily for 84 d

257 hypotensive efficacy and safety of AR-13324 ophthalmic solution compared with a positive control, la

258 g effect of CLLO, CLHI, or daily latanoprost ophthalmic solution in the same monkeys.

259 rated greater IOP reduction than latanoprost ophthalmic solution on day 3 (P = 0.001) and day 5 (P =

260 Latanoprost ophthalmic solution resulted in IOP reduction of 5.4+/-1

261 To compare povidone-iodine 1.25% ophthalmic solution with topical antibiotics for treatme

262 ular and systemic safety of netarsudil 0.02% ophthalmic solution, a rho-kinase inhibitor and norepine

263 ompared with a positive control, latanoprost ophthalmic solution, in patients with open-angle glaucom

264 effective as delivery with daily latanoprost ophthalmic solution.

265 type profiles and quantity of complaints by ophthalmic subspecialty, practice setting, physician gen

266 Screening tests were stratified by ophthalmic subspecialty.

267 unctival myxoma (J Ophthalmol (1);1-5, 2014; Ophthalmic Surg Lasers Imaging 39(6):514-6, 2008).

268 revent potentially devastating consequences (Ophthalmic Surg Lasers Imaging 39(6):514-6, 2008).

269 us pigmentation, and endocrine overactivity (Ophthalmic Surg Lasers Imaging 39(6):514-6, 2008).

270 ants were consultant (attending) and trainee ophthalmic surgeons and anesthetists, operating departme

271 tioning in mock surgical trials involving 17 ophthalmic surgeons.

272 Applying OCT to ophthalmic surgery may have implications for surgical de

273 OCT Visualization During En Face Retinal and Ophthalmic Surgery) study, a single-site, multisurgeon,

274 with a microscope-integrated iOCT system for ophthalmic surgery.

275 microscope-integrated intraoperative OCT in ophthalmic surgery.

276 Participants included patients undergoing ophthalmic surgery.

277 d without glaucoma from the Veterans Affairs Ophthalmic Surgical Outcomes Data Project were compared.

278 g simulation-based training or assessment of ophthalmic surgical skills among health professionals.

279 immersive simulation course specifically for ophthalmic surgical teams.

280 All persons were under ophthalmic surveillance and all cases had >/=1 confirmat

281 Ophthalmic surveillance was performed on patients in a m

282 newly diagnosed T1DM or T2DM who were under ophthalmic surveillance, we identified the incidence and

283 cacy and safety of once-daily nepafenac 0.3% ophthalmic suspension versus vehicle, based on clinical

284 Astronaut ophthalmic syndrome.

285 ondition that we suggest calling, "astronaut ophthalmic syndrome." We maintain that this condition is

286 bridge can result in arterial emboli to the ophthalmic system with optic nerve, retinal and choroida

287 Ophthalmic technicians performed a screening examination

288 Ophthalmic technicians performing a subset of screening

289 abstracts and yielded 43 articles, which the Ophthalmic Technology Assessment Committee Oculoplastics

290 re is considerable overlap of mandibular and ophthalmic terminal fields, with only a small maxillary

291 gap between successful vision screening and ophthalmic treatment, a gap that often occurs in low-soc

292 ACC might be used to evaluate the effect of ophthalmic treatment, rehabilitation programs, or assist

293 me to first diagnosis), visual acuities, and ophthalmic treatments prescribed were collected for each

294 tocoagulation, optical coherence tomography, ophthalmic ultrasound, angioinhibitory drugs, vitrectomy

295 t was diagnosed in the community by a mobile ophthalmic unit and patients were referred to a hospital

296 tomography showed an enlarged right superior ophthalmic vein.

297 es of Colour Doppler imaging (CDI) assessing ophthalmic vessels and provide an inventory of the avail

298 Colour Doppler analysis of ophthalmic vessels has been proposed as a promising tool

299 tient ages ranged from 2 to 27 years at last ophthalmic visit, and follow-up ranged from 0 to 83 mont

300 d hospital settings were analyzed, including ophthalmic zoster (OZ) and postherpetic neuralgia (PHN).